top of page
Weixin Image_20231015044457_edited.jpg

On 12 October 2023, the Danish Life Science Cluster, Nordic Life Science Partners, and the Lecheng Administration signed a Strategic Cooperation Agreement in Copenhagen within health and life science that was witnessed by Ms. XIE Jing, Vice Governor of Hainan Province. 

China Market Access via Fast-track Approval Procedures for Medical Devices & Medicines at Hainan Boao Lecheng International Medical Tourism Pilot Zone

About Us - Mission

About Us - Purpose & Mission

The purpose of the Nordic Life Science Platform (NLSP) is to give Nordic Life Science & Welfare Technology companies a more safe, efficient, and easier access to China's healthcare market by taking advantage of the preferential policies and opportunities at Hainan Boao Lecheng International Medical Zone that is part of the newly launched Hainan Free Trade Port that covers all of Hainan Island. 

Our mission is to match the demand for innovative medical products and solutions by the hospitals in Hainan Boao Lecheng with the supply of Nordic life science companies for the benefit of Chinese patients, and that way help develop new market opportunities in China.

Through NLSP, Hainan Boao Lecheng serves as a gateway and stepping-stone to the rest of Mainland China's Healthcare Market.

To explore the market opportunities closer, the Nordic Life Science Partners ApS has established a Partnership with the Danish Life Science Cluster, Innovation Center Denmark in Shanghai, and Trade Council in China.

Concept

Concept - One-Stop Service

Although China is the world’s second largest market for both medical devices and medicines, many Nordic life science companies hold back from starting exports or own sales in China because of lack of market knowledge and entry barriers, and therefore perceive it as too difficult and risky. This cuts them off from a very large growth market.

To lower the entry barriers, we have gathered a team of experts with many years of know-how and experience from advising and assisting Nordic companies entering and operating in China.

NLSP is a one-stop service platform that helps Nordic companies to explore and enter China's healthcare market. We reduce the challenges and time-to-market by offering companies expert advice and supporting services.

Operation Room.jpeg
Our Offering

Offering - Step-by-Step Entry Model

NLSP delivers a proven Step-by-Step Market Entry Model that supports companies all the way but also give them the option to stop or pause after each step of the process to decide their next move into the Chinese market.

With NLSP and our local partners in China, our experienced team will assist Nordic life science & welfare technology companies to enter China's healthcare market and to take advantage of the preferential policies and opportunities at Hainan Boao Lecheng.

We offer expert advice and supporting services such as project management, legal assistance,  market research, partner search, matchmaking, IPR protection, company set-up, registrations & approvals.

STEP-BY-STEP FLOW CHART

Step-by-Step Flow Chart (22 January 2024).png
HBL Aerial1.jpg

Hainan Boao Lecheng Intl. Medical Zone 

Boao Lecheng International Medical Tourism Pilot Zone is a special medical zone in China that has been granted preferential policies and incentives that aim to create a world-class international medical destination and cluster for advanced medical treatment, professional rehabilitation, medical R&D, and technological innovation in China.

It offers a special fast-track approval procedure that makes it easier and quicker to register, import, sell and sell "Innovative" medical devices and medicines in need by the hospitals in Hainan Boao Lecheng that are not yet registered in China with an NMPA approval. 

 

As of February 2024, 378 medical products have been approved by Hainan MPA for exclusive use in Hainan Boao Lecheng.

Criteria: 1) Product cannot have been approved in China but with CE mark/FDA license/PMDA approval, 2) Product shall be innovative and cannot be replaced by an already approved predicate in China, and 3) Product shall be used for a specific medical purpose at designated medical institution.

Moreover, it is the only place in China where it is possible to conduct Real-World Data (RWD) Studies of the use of medical devices and medicines imported under the fast-track approval procedure that can supplement the application for the NMPA registration which will speed up the approval process for selling in the rest of Mainland China.

As of June 2023, 24 licensed medical devices and drugs have been included in the RWD Program in which 7 medical devices and 3 drugs have obtained NMPA approval by using RWD studies at HBL.

CURRENT STATUS

When fully developed, Hainan Boao Lecheng is planned to cover 21 km2 with a total of 3 km2 of constructed land. Total construction costs are estimated at RMB 100 billion (USD 16 billion)

 

Today, 22 hospitals/medical centers & 6 medical service centres are in operation with 5 new hospitals scheduled to open in Q1, 2024, and ten more planned.  

When completed, it will provide 12,000 hospital beds, employ 28,500 medical personnel including 3,500 R&D staff, and by 2025 provide 1.5 million medical consultations per year. In 2022, a total of 189,300 medical tourists were welcomed.

Hainan
China-Hainan Maps, No background Colors.png
5.jpg
Our Team

Team - Expert Advice and Support

Our expert team has many years of operational experience from doing business in China, and welcome Nordic life science & welfare technology companies to enter the Chinese healthcare market and to take advantage of the preferential policies and opportunities at Hainan Boao Lecheng International Medical Zone.

2, Square_edited.jpg
  • Noam David Stern

Noam David Stern,
Co-founder & Owner, China

WeChat Image_20171022155913_edited_edite
  • Daisy Du

Daisy Du,
Legal Counsel, China

Sharon_edited.jpg
  • Sharon Xu

Sharon Xu,
Project Manager, China

_RBL1465_edited_edited.jpg
  • Peter Oelbye

Peter Ølbye,
Co-founder, Denmark

Marcus
  • Marcus Woldsen

Marcus Woldsen,
Project Manager, Denmark

Frederik
  • Frederik Krebs

Frederik Krebs,
Project Manager, Denmark

Partners

Partnership

NLSP11.png
DLSC logo.jpg
ICDK (color background).jpg
Trade Council.png
Contact

Contact

Nordic Office

Lyngby Hovedgade 17, 2. th,
2800 Kgs. Lyngby, Denmark

Mobile: +45 2530 8027

info@nlsp.dk

​China Office

Room 2003, Level 20, 989 Changle Road,

Xuhui, Shanghai 200031, China

Mobile: +86 136 1169 1358

info@nlsp.dk

bottom of page